About Gerosynth Laboratories
Gerosynth Laboratories is a private company based in Bloomington, Minnesota, incorporated in 2022 in Delaware. It has reported $6,208,000 raised in five offerings on Form D since March 2023. Its chief executive is Alisha O'Dell.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 2, 2024 | Dec 12, 2024 | $1,638,500of $5.0M target | 15 | $109K | SAFEsRule 506(b) | Form D ↗ |
| Apr 15, 2024 | May 9, 2024 | $1,379,500of $2.0M target | 23 | $59,978 | SAFEsRule 506(b) | Form D ↗ |
| Oct 18, 2023 | Aug 11, 2023amended Oct 18, 2023 | $2,680,000of $3.0M target | 34 | $78,824 | SAFEsRule 506(b) | Form D/A ↗1 earlier filing |
| Jun 30, 2022 | Mar 13, 2023 | $255,000of $400K target | 5 | $51,000 | SAFEsRule 506(b) | Form D ↗ |
| Jun 30, 2022 | Aug 30, 2022amended Feb 28, 2023 | $255,000of $400K target | 5 | $51,000 | SAFEsRule 506(b) | Form D/A ↗1 earlier filing |
| Total, five offerings | $6,208,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Gerosynth Laboratories's Form D filed Dec 12, 2024.
EC
Erin Clark
Executive officer and director
BH
Brian Hatlevig
Director
BP
Bethany Pope
Executive officer and director
AD
Alisha O'Dell
CEO and director
Earlier filings also listed Pat Chuinard (executive officer and director, last listed May 2024), Paige Scherer (director, last listed Mar 2023), Laurie Chuinard (director, last listed Mar 2023) and Amy Hatlevig (director, last listed Mar 2023).